Robeco Institutional Asset Management B.V. Acquires 3,141 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Robeco Institutional Asset Management B.V. lifted its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 5.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 65,243 shares of the biotechnology company’s stock after purchasing an additional 3,141 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Axon Enterprise were worth $38,775,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. Asset Dedication LLC boosted its holdings in Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after purchasing an additional 18 shares during the last quarter. R Squared Ltd acquired a new position in Axon Enterprise during the fourth quarter worth approximately $91,000. SteelPeak Wealth LLC boosted its stake in shares of Axon Enterprise by 125.6% during the 4th quarter. SteelPeak Wealth LLC now owns 1,453 shares of the biotechnology company’s stock worth $864,000 after acquiring an additional 809 shares during the period. Mayflower Financial Advisors LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth approximately $256,000. Finally, Perigon Wealth Management LLC acquired a new stake in Axon Enterprise during the 4th quarter valued at $488,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Trading Up 2.1 %

Shares of Axon Enterprise stock opened at $653.43 on Friday. The firm’s 50-day moving average price is $619.32 and its two-hundred day moving average price is $479.00. The company has a market capitalization of $49.82 billion, a price-to-earnings ratio of 168.85, a PEG ratio of 6.09 and a beta of 1.04. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12-month low of $247.04 and a 12-month high of $698.67.

Insider Activity at Axon Enterprise

In related news, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the sale, the director now owns 2,392 shares of the company’s stock, valued at $1,631,487.52. This trade represents a 34.52 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 21,834 shares of the company’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the transaction, the insider now directly owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock valued at $30,721,337 over the last ninety days. 6.10% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts have commented on AXON shares. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Robert W. Baird increased their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Needham & Company LLC boosted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Northland Securities increased their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Finally, The Goldman Sachs Group lifted their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $524.85.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.